Condition
Autosomal Dominant Polycystic Kidney Disease (ADPKD) clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Autosomal Dominant Polycystic Kidney Disease (ADPKD) clinical trials that are recruiting, at sites in 7 countries (most in United States (2), Italy (1), United Kingdom (1)). By phase: Phase 1 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 7Countries
Newest Autosomal Dominant Polycystic Kidney Disease (ADPKD) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| VX-407 pharmacokinetics after a single dose in adults with ADPKD | Phase 1 | Lincoln, Nebraska | Recruiting | Oct 9, 2026 |
| How VX-407 interacts with common birth control pills | Phase 1 | Montreal | Recruiting | Aug 28, 2026 |
| Renal embolization with EVOH for adults on dialysis with ADPKD | — | Pavia, Lombardy | Recruiting | Apr 17, 2026 |
| Ren-Nu: a kidney-focused ketogenic diet program for people with polycystic kidney disease | — | Cleveland, Ohio | Recruiting | Mar 6, 2026 |
| High blood pressure in children and teenagers at risk of ADPKD | — | London | Recruiting | Dec 2, 2025 |
| Evaluating the safety of PYC-003 for treating a kidney disease | Phase 1 | Southport, Gold Coast and 11 other locations | Recruiting | Dec 3, 2024 |
All recruiting trials (6)
-
VX-407 pharmacokinetics after a single dose in adults with ADPKD
This study tests how VX-407 is absorbed, distributed, metabolized, and excreted after a one-time oral dose in adults with polycystic kidney disease.
-
How VX-407 interacts with common birth control pills
This study tests whether VX-407 affects how birth control pills work in people with ADPKD.
-
Renal embolization with EVOH for adults on dialysis with ADPKD
This study tests whether blocking blood flow to very large polycystic kidneys with the liquid embolic EVOH can shrink kidney size and reduce symptoms in adults on dialysis with ADPKD.
-
Ren-Nu: a kidney-focused ketogenic diet program for people with polycystic kidney disease
This 16-week pilot will try a dietitian-led, kidney-safe ketogenic program plus KetoCitra in adults with ADPKD to improve metabolic health.
-
High blood pressure in children and teenagers at risk of ADPKD
This project will use MRI, blood tests, arterial stiffness measures, and ambulatory blood pressure monitoring to see how common high blood pressure is in 12–17-year-olds who have a parent with ADPKD.
-
Evaluating the safety of PYC-003 for treating a kidney disease
This study is testing a new drug called PYC-003 to see if it's safe for people with a specific type of kidney disease and healthy adults.
Quick answers
How many Autosomal Dominant Polycystic Kidney Disease (ADPKD) clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in United States (2 trials), Italy (1 trial), United Kingdom (1 trial), Canada (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.